ARCHIVES

Cancer Patient Lobby Outlines Agenda For FDA Reform, Seeks Role In Discussion

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989